Anatara Lifesciences Ltd - Asset Resilience Ratio

Latest as of December 2024: 2.84%

Anatara Lifesciences Ltd (ANR) has an Asset Resilience Ratio of 2.84% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ANR capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$50.00K

≈ $35.38K USD Cash + Short-term Investments

Total Assets

AU$1.76 Million

≈ $1.25 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Anatara Lifesciences Ltd's Asset Resilience Ratio has changed over time. See Anatara Lifesciences Ltd (ANR) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Anatara Lifesciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Anatara Lifesciences Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$50.00K	2.84%
Total Liquid Assets	AU$50.00K	2.84%

Asset Resilience Insights

Limited Liquidity: Anatara Lifesciences Ltd maintains only 2.84% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Anatara Lifesciences Ltd Industry Peers by Asset Resilience Ratio

Compare Anatara Lifesciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
BB Biotech AG SW:BION	Biotechnology	0.05%
Concord Biotech Limited NSE:CONCORDBIO	Biotechnology	18.00%
Pharming Group NV AS:PHARM	Biotechnology	7.13%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
Clarity Pharmaceuticals Ltd AU:CU6	Biotechnology	73.99%
Yantai Zhenghai Bio-Tech Co Ltd SHE:300653	Biotechnology	56.48%

Annual Asset Resilience Ratio for Anatara Lifesciences Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Anatara Lifesciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	3.00%	AU$50.09K ≈ $35.44K	AU$1.67 Million ≈ $1.18 Million	-0.53pp
2023-06-30	3.52%	AU$50.00K ≈ $35.38K	AU$1.42 Million ≈ $1.00 Million	+0.69pp
2022-06-30	2.83%	AU$50.00K ≈ $35.38K	AU$1.77 Million ≈ $1.25 Million	+1.67pp
2021-06-30	1.16%	AU$50.00K ≈ $35.38K	AU$4.33 Million ≈ $3.06 Million	--
2020-06-30	0.00%	AU$0.00 ≈ $0.00	AU$3.34 Million ≈ $2.37 Million	--
2019-06-30	63.46%	AU$4.05 Million ≈ $2.87 Million	AU$6.38 Million ≈ $4.52 Million	+0.27pp
2018-06-30	63.19%	AU$6.20 Million ≈ $4.39 Million	AU$9.81 Million ≈ $6.94 Million	-24.99pp
2017-06-30	88.17%	AU$10.86 Million ≈ $7.68 Million	AU$12.32 Million ≈ $8.71 Million	+34.74pp
2016-06-30	53.43%	AU$7.44 Million ≈ $5.26 Million	AU$13.92 Million ≈ $9.85 Million	-18.59pp
2015-06-30	72.03%	AU$4.05 Million ≈ $2.87 Million	AU$5.63 Million ≈ $3.98 Million	--

pp = percentage points

About Anatara Lifesciences Ltd

AU:ANR Australia Biotechnology

Market Cap

$1.92 Million

AU$2.72 Million AUD

Market Cap Rank

#29994 Global

#1763 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$1.64